CDKN2A and hepatocellular carcinoma: USP7 promotes HCC cell growth by forming a complex with thyroid hormone receptor-interacting protein 12 (TRIP12) and stabilizing p14 (ARF) ubiquitination, thereby promoting HCC progression (150).